Loading...
Communiqués du point de contrôle (CPC)
  |  
last updated: 22 juil. 2026
Informations générales
GPS - Global Pneumococcal Sequencing Project
Point(s) de contrôle qui ont collecté ou reçu l’information
  • ABSCH-CP-GB-207653-5 Points de contrôle The Office for Product Safety and Standards (OPSS)
    The National Focal Point in the Department for Environment, Food & Rural Affairs (Defra) is responsible for:

    - requesting due diligence declarations from users on receipt of research funding;

    - the receipt of due diligence declarations from users conducting research and development in the UK at two checkpoints (receipt of research funding and placing a product on the market); 

    - submitting due diligence declarations as checkpoint communiqués on the ABS Clearing House.

     The Office for Product Safety and Standards (OPSS) is responsible for:

    - monitoring user compliance in the UK; 

    - where necessary enforcing compliance obligations of UK users of genetic resources and genetic resources associated with traditional knowledge. 

Information collectée ou reçue par le point de contrôle
Le certificat de conformité internationalement reconnu n'est pas disponible
  • Cuba
- Organisation : Ministerio de Ciencia, Tecnología y Medio Ambiente (Ministry of Science, Technology and Environment) (CITMA) | ABSCH-CON-GB-300084-1
Organisation :
Ministerio de Ciencia, Tecnología y Medio Ambiente (Ministry of Science, Technology and Environment) (CITMA)
Agence gouvernementale (nationale/fédérale)
Calle 18 A#4118 e/41 y 47
Havana,
11300, Cuba
Téléphone : (+53) 78315588, +53 78397549,
Télécopieur :
Streptococcus pneumoniae isolates obtained from human patients.

*
  • Micro-organismes ()
'Request for Authorisation for Access to Genetic Resources' submission by Wellcome Sanger Institute - signed by Wellcome Sanger Institute on 21 December 2023, signed by Provider organisation in n.d. February 2024 and signed by Cuba's ABS National Focal Point on behalf of Ministry of Science, Technology and Environment on 11 March 2024

*
Mutually Agreed Terms mentioned in attachment to 'Request for Authorisation for Access to Genetic Resources' submission by Wellcome Sanger Institute - signed by Wellcome Sanger Institute on 21 December 2023, signed by Provider organisation in n.d. February 2024 and signed by Cuba's ABS National Focal Point on behalf of Ministry of Science, Technology and Environment on 11 March 2024

*
2025-07-31
Information sur l’utilisation de la ou des ressource(s) génétique(s)
The Global Pneumococcal Sequencing (GPS) project utilizes whole genome sequencing of Streptococcus pneumoniae isolates, particularly from low and middle income countries, to monitor genetic variation and evolutionary changes that impact the effectiveness of pneumococcal conjugate vaccines (PCVs). The data supports understanding and tracking the genetic resources of pneumococci to inform vaccine development and public health strategies.

*
- Organisation : Wellcome Sanger Institute () | ABSCH-CON-GB-262541-2
Organisation :
Wellcome Sanger Institute ()
Wellcome Genome Campus Hinxton
Cambridge,
CB10 1SA, Royaume-Uni de Grande-Bretagne et d'Irlande du Nord
Téléphone : +44 (0)1223 496920,
Télécopieur : +44 (0)1223 494919,
E-mail : nagoya@sanger.ac.uk,
2025-08-26
Informations supplémentaires
Person or entity to whom prior informed consent (PIC) was granted: Instituto Pedro Kouri and Wellcome Sanger Institute

*